Ligand validation:3TY9

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 3TY9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3TY9_AMP_C_900	66%	43%	0.159	0.966	0.95	1.27	1	1	1	0	100%	1
3TY9_AMP_D_900	62%	43%	0.172	0.964	0.97	1.21	1	2	2	0	100%	1
3TY9_AMP_A_900	61%	42%	0.17	0.961	0.92	1.3	1	2	1	0	100%	1
3TY9_AMP_B_900	53%	44%	0.161	0.924	0.93	1.23	1	2	0	0	100%	1
4E6N_AMP_C_902	84%	47%	0.117	0.988	0.9	1.14	1	2	1	0	96%	1
8YNQ_AMP_D_504	100%	43%	0.041	0.99	0.96	1.26	1	2	11	0	100%	1
3G89_AMP_B_304	100%	32%	0.038	0.986	1.05	1.63	1	4	6	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.78
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.